I
InspireMD, Inc. (NSPR)
1.59
0.00 (0.00%)
Get all premium features to the best stock analysis tool
1.59
0.00 (0.00%)
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
| Name | Position |
|---|---|
| Dr. Peter A. Soukas M.D. | Chief Medical Officer |
| Dr. Sol J. Barer Ph.D. | Special Advisor to the Board |
| Mr. Amir Kohen | Executive VP of Finance & Regional Manager |
| Mr. Andrea Tommasoli | Chief Operating Officer |
| Mr. Michael A. Lawless | Chief Financial Officer |
| Mr. Pete J. Ligotti | Executive VP & GM of North America |
| Mr. Shane Thomas Gleason | Chief Commercial Officer |
| Ms. Donna DeChant |
| Date | Type | Document |
|---|---|---|
| 2026-03-18 | 8-K | form8-k.htm |
| 2026-03-04 | 8-K | form8-k.htm |
| 2025-12-19 | 8-K | form8-k.htm |
| 2025-11-18 | S-8 | forms-8.htm |
| 2025-11-10 | 10-Q | form10-q.htm |
| 2025-11-04 | 8-K | form8-k.htm |
| 2025-09-17 | 8-K | form8-k.htm |
| 2025-09-08 | 8-K/A | form8-ka.htm |
| 2025-08-12 | CORRESP | filename1.htm |
| 2025-08-06 | S-3 | forms-3.htm |
| Vice President of Human Resources & Organizational Development |